FDA Seeks to Improve Patient Communication on LASIK Benefits and Risks Through Issuance of Draft GuidanceJuly 27, 2022
FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public HealthJuly 22, 2022
FDA Provides Educational Resources for Parents and Caregivers to Support Confidence for Imported Infant Formula ProductsJuly 14, 2022
Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, AdjuvantedJuly 13, 2022
FDA Warns Four Companies for Selling Tainted Honey-based Products with Hidden Active Drug IngredientsJuly 12, 2022
FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and CaregiversJuly 6, 2022
